| Company Name: |
Labnetwork lnc. |
| Tel: |
+86-27-50766799 +86-18062016861 |
| Email: |
contact@labnetwork.com |
|
| | 3-Hydroxyestra-1,3,5(10)-trien-17-one benzoate Basic information |
| Product Name: | 3-Hydroxyestra-1,3,5(10)-trien-17-one benzoate | | Synonyms: | (13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl) benzoate;benzoic acid (17-keto-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl) ester;Estradiol Benzoate EP Impurity G;3-Hydroxyestra-1,3,5(10)-trien-17-one benzoate;OESTRONEBENZOATE;17-Oxoestra-1,3,5(10)-trien-3-yl Be;Estra-1,3,5(10)-trien-17-one, 3-(benzoyloxy)-;Estradiol Benzoate Impurity 7 (Estradiol Benzoate EP Impurity G) | | CAS: | 2393-53-5 | | MF: | C25H26O3 | | MW: | 374.47 | | EINECS: | | | Product Categories: | Steroids | | Mol File: | 2393-53-5.mol |  |
| | 3-Hydroxyestra-1,3,5(10)-trien-17-one benzoate Chemical Properties |
| Melting point | 217-220 °C | | Boiling point | 463.47°C (rough estimate) | | density | 1.0636 (rough estimate) | | refractive index | 1.5460 (estimate) |
| | 3-Hydroxyestra-1,3,5(10)-trien-17-one benzoate Usage And Synthesis |
| Safety Profile | Suspected carcinogen
with experimental carcinogenic,
neoplastigenic, tumorigenic, and teratogenic
data. Other experimental reproductive
effects. Mutation data reported. A steroid
drug for the treatment of menopause. When
heated to decomposition it emits acrid
smoke and irritating fumes. |
| | 3-Hydroxyestra-1,3,5(10)-trien-17-one benzoate Preparation Products And Raw materials |
|